Abstract
As discussed in Chapter 1, atherosclerotic lesions appear early in life.1,2 Considering its high incidence, which only increases with aging,3 the active search for coronary lesions, in the asymptomatic general population, does not seem reasonable. Lesions will often be found but will not necessarily be affecting myocardial perfusion in a significant way. Preservation of perfusion relates to other factors, including (1) the capacity of coronary vessels to dilate, known as coronary blood flow reserve (CBFR) and (2) the existence of a complex net of collateral vessels at the microcirculatory level. Whether coronary lesions will adversely affect myocardial blood flow (MBF) depends highly on the impact they have on CBFR and the existence or absence of good-quality collateral vessels. Evaluation of MBF, under stress, helps to determine the presence of coronary artery disease (CAD) affecting CBFR. The extent of myocardial ischemia and the degree of left ventricular dysfunction are key variables for determining prognosis that can be evaluated in nuclear cardiology using myocardial perfusion imaging (MPI). To test CBFR in nuclear cardiology, several stress modalities can be applied, including exercise, dipyridamole, adenosine, exercise combined with dipyridamole or adenosine, and dobutamine. Other less frequent forms of stress such as arbutamine, cardiac pacing, mental stress, and the cold pressor test, have also been used. These stress modalities are reviewed in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea: preliminary report. JAMA 1986; 256: 2859–2862.
McNamara JJ, Molot MA, Stremple JF, Cutting RT. Coronary artery disease in combat casualties in Vietnam. JAMA. 1971;216:1185–1187.
Tuzcu EM, Kapadia SR, Tutar E, et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults— evidence from intravascular ultrasound. Circulation 2001; 103: 2705–2710.
Gibbons RJ. ACC/AHA 2002 guidelines update for exercise testing. http://www.acc.org.
Fletcher GF, Balagy G, Froelicher VF, et al. Exercise standards: a statement for healthcare professionals from the American Heart Association writing group—special report. Circulation 1995; 91: 580–622.
Stuart RJ, Ellestad MH. National survey of exercise stress testing facilities. Chest 1980; 77: 94–97.
Borg GA. Psychophysical basis of perceived exertion. Med Sci Sports Exerc. 1982;14:377–381.
Berman DS, Hayes SW, Germano G. Assessment of myocardial perfusion and viability with technetium-99m perfusion agents. In Depuey EG, Garcia EV, Berman DS (eds). Cardiac SPECT Imaging Philadelphia: Lippincott Williams & Wilkins; 2001: 179–210.
Mark DB, Hlatky MA, Harrell FE Jr, et al. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med. 1987; 106: 793–800.
Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996; 93 (5): 905–914.
Myers J, Prakash M, Froelicher V, et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002; 336 (11): 793–801.
Metra M, Faggiano P, D’Aloi, et al. Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure. J Am Coll Cardiol. 1999;33:943–950.
Travin MI, Wexler JP. Pharmacological stress testing. Semin Nucl Med. 1999; 29: 298–318.
Cohen MC. A snapshot of nuclear cardiology in the United States. Am Soc Nucl Cardiol Newsletter 1998; 5: 13.
Smits P, Corstens FHM, Aengevaeren WRM, Wackers FJT, Thien T. False negative dipyridamole-thallium-201 myocardial imaging after caffeine ingestion. J Nucl Med. 1991;32:1538–1541.
Henzlova M, Squire A, Kim-Schuleger L, et al. Screening for coronary artery disease prior to liver transplantation. J Nucl Cardiol. 2003; 10(1):S-54.
O’Byrne, Rodriguez EA, Maddahi J, et al. Comparison of myocardial washout rate of thallium-201 between rest, dipyridamole with and without aminophylline, and exercise states in normal subjects. Am J Cardiol. 1989;64:1022–1028.
Wilson RF, White CW. Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans. Circulation 1986, 73: 444–451.
Picano E, Lattanzi F, Masini M, Distante A, L’Abbate A. High dose dipyridamole echocardiography test in effort angina pectoris. J Am Coll Cardiol.. 1986; 8: 848–854.
Lette J, Tatum JL, Fraser S, et al. Safety of dipyridamole testing in 73,806 patients: the multicenter dipyridamole safety study. J Nucl Cardiol. 1995; 2: 3–17.
Ranhosky A, Kempthorne-Rawson J. The safety of intravenous dipyridamole thallium myocardial perfusion imaging: intravenous dipyridamole thallium imaging study group. Circulation 1990; 81: 1205–1209.
Hachamovitch RJ, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans—what is the warranty period of a normal scan? J Am Coll Cardiol. 2003;41:1329–1340.
Feldman RL, Nichols WM, Pepine CJ, Conti CR. Acute effects of intravenous dipyridamole on regional coronary hemodynamics and metabolism. Circulation 1981; 64: 333–334.
Treuth MG, Reyes GA, He ZX, et al. Tolerance and diagnostic accuracy of an abbreviated adenosine infusion for myocardial scintigraphy: a randomized prospective study. J Nucl Cardiol. 2001; 8: 548–554.
Abreu A, Mahmarian JJ, Nishimura S, et al. Tolerance and safety of pharmacologic coronary vasodilation with adenosine in association with thallium-201 scintigraphy in patients with coronary artery disease. J Am Coll Cardiol. 1991; 18: 730–735.
Cerqueira MD, Verani MS, Schwaiger M, et al. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan multicenter trial registry. J Am Coll Cardiol. 1994; 23: 384–390.
Johnston DL. Hemodynamic responses and adverse effects associated with adenosine and dipyridamole pharmacologic stress testing: a comparison in 2000 patients. Mayo Clin Proc 1995; 70: 331–336.
Coyne EP, Belvedere DA, Vande-Streek PR, et al. Thallium-201 scintigraphy after intravenous infusion of adenosine compared with exercise thallium testing in the diagnosis of coronary artery disease. J Am Coll Cardiol. 1991; 17 (6): 1289–1294.
Verani MS, Mahmarian JJ, Hisxon JB, et al. Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation. 1990;82(1):80–87.
O’Keefe JH Jr, Bateman TM, Silvestri R, et al. Safety and diagnostic accuracy of adenosine thallium-201 scintigraphy in patients unable to exercise and those with left bundle branch block. Am Heart J. 1992; 124 (3): 614–621.
Klodas E, Miller TD, Christian TF, et al. Prognostic significance of ischemic electrocardiographic changes during vasodilator stress testing in patients with normal SPECT images. J Nucl Cardiol. 2003; 10: 4–8.
Abbott BG, Afshar M, Berger AK, Wackers FJ. Prognostic significance of ischemic electrocardiographic changes during adenosine infusion in patients with normal myocardial perfusion imaging. J Nucl Cardiol. 2003; 10: 9–16.
Vitola JV, Brambatti JC, Caligaris F, et al. Exercise supplementation to dipyridamole prevents hypotension, improves electrocardiogram sensitivity, and increases heart-to liver activity ratio on Tc-99m sestamibi imaging. J Nucl Cardiol. 2001; 8: 652–659.
Elliot MD, Holly TA, Leonard SM, Hendel RC. Impact of an abbreviated adenosine protocol incorporating adjunctive treadmill exercise on adverse effects and image quality in patients undergoing stress myocardial perfusion imaging. J Nucl Cardiol. 2000; 7: 584–589.
Samady H, Wackers FJ, Joska TM, et al. Pharmacologic stress perfusion imaging with adenosine: role of simultaneous low-level treadmill exercise. J Nucl Cardiol. 2002; 9: 188–196.
Stein L, Burt R, Oppenheim B, Schauwecker D, Fineberg N. Symptom-limited arm exercise increases detection of ischemia during dipyridamole tomographic thallium stress testing in patients with coronary artery disease. Am J Cardiol. 1995; 75: 568–572.
Verzijlbergen JF, Vermeersch PH, Laarman Ascoop CA. Inadequate exercise leads to suboptimal imaging after dipyridamole combined with low-level exercise unmasks ischemia in symptomatic patients with non-diagnostic thallium-201 scans who exercise submaximally. J Nucl Med. 1991; 32: 2071–2078.
Taillefer R. Technetium-99m sestamibi myocardial imaging: same day rest-stress studies and dipyridamole. Am J Cardiol. 1990;66:80E–84E.
Bergman H, Bjorntorp P, Conradson TB, Fahlen M, Stenberg J, Varnauskas E. Enzymatic and circulatory adjustments to physical training in middle aged men. Eur J Clin Invest 1973; 3: 414–418.
Primeau M, Taillefer R, Essiambre R, Lambert R, Honos G. Technetium 99m sestamibi myocardial perfusion imaging: comparison between treadmill, dipyridamole and transesophageal atrial pacing “stress” tests in normal subjects. Eur J Nucl Med. 1991; 18: 247–251.
Casale PN, Guiney TE, Strauss W, Boucher CA. Simultaneous low level treadmill exercise and intravenous dipyridamole stress thallium imaging. Am J Cardiol. 1988; 62: 799–802.
Ignaszewski AP, McCormick LX, Heslip PG, McEwan AJ, Humen DP. Safety and clinical utility of combined intravenous dipyridamole/ symptom-limited exercise stress test with thallium-201 imaging in patients with known or suspected coronary artery disease. J Nucl Med. 1993; 34: 2053–2061.
Laarman G, Niemeyer MG, Van Der Wall EE, Verzijlbergen FJ, Bruschke AV, Ascoop CA. Dipyridamole thallium testing: noncardiac side effects, cardiac effects, electrocardiographic changes and hemodynamic changes after dipyridamole infusion with or without exercise. Int J Cardiol. 1988; 20: 231–238.
Hashimoto A, Palmer EL, Scott JA, Abraham SA, Fischman AJ, Force TL, et al. Complications of exercise and pharmacologic stress tests: differences in younger and elderly patients. J Nucl Cardiol. 1999; 6: 612–619.
Thomas GS, Prill NV, Majmundar H, et al. Treadmill exercise during adenosine infusion is safe, results in fewer adverse reactions, and improves myocardial perfusion image quality. J Nucl Cardiol. 2000; 7 (5): 439–446.
Pennell DJ, Mavrogeni SI, Forbat SM, et al. Adenosine combined with dynamic exercise for myocardial perfusion imaging. J Am Coll Cardiol. 1995; 25 (6): 1300–1309.
Vitola JV, Ludwig V, Cunha Pereira Neto C, et al. Exercise and dipyridamole combined myocardial scintigraphy allows early evaluation of perfusion and function. J Nucl Cardiol. 2003; 10(1)S:87.
Ebersole DG, Heironimus J, Toney MO, Billingsley J. Comparison of exercise and adenosine technetium—99m sestamibi myocardial scintigraphy for diagnosis of coronary artery disease in patients with left bundle branch block. Am J Cardiol. 1993; 71: 450–453.
Ellestad MH (ed). Predictive implication. In Stress Testing: Principles and Practice. New York University Press; 2003: 271–307.
Holly TA, Satran A, Bromet DS, et al. The impact of adjunctive adenosine infusion during exercise myocardial perfusion imaging: results of both exercise and adenosine stress test. J Nucl Cardiol. 2003; 10: 291–296.
Geleijnse ML, Elhendy A, Fioretii PM, Roelandt JR. Dobutamine stress myocardial perfusion imaging. J Am Coll Cardiol. 2000; 36 (7): 2017–2020.
Tuttle RR, Mills J. Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res. 1975; 36: 185–195.
Leier CV, Heban PT, Huss P, et al. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation 1978; 58: 466–475.
Mason JR, Palac RT, Freeman ML, et al. Thallium scintigraphy during dobutamine infusion: non exercise-dependent screening test for coronary disease. Am Heart J. 1984; 107: 481–485.
Palac RT, Coombs BJ, Kudenchuk PJ, et al. Two-dimensional echocardiography during dobutamine infusion—comparison with exercise testing in evaluation of coronary disease. Circulation. 1984;70 Suppl II:184.
Secknus MA, Marwick TH. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3001 studies over 5 years. J Am Coll Cardiol. 1997; 29: 1234–1240.
Leier CV, Unverferth DV. Drugs five years later: dobutamine. Ann Intern Med. 1983; 99: 490–496.
Kates RE, Leier CV. Dobutamine phamacokinetics in severe heart failure. Clin Pharmacol Ther 1978; 24: 537–541.
Raza JA, Reeves WC, Movahed A. Pharmacological stress agents for evaluation of ischemic heart disease. Int J Cardiol. 2001; 81 (2–3): 157–167.
Tadamura E, Iida H, Matsumoto K, et al. Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men. J Am Coll Cardiol. 2001; 37: 130–136.
Cancer B, Karanfil A, Uysal U. Effect of an additional atropine injection during dobutamine infusion for myocardial SPECT. J Nucl Med Comm. 1997; 18: 567–573.
Elhendy A, Valkema R, Van Domburg RT, et al. Safety of dobutamine-atropine stress myocardial perfusion scintigraphy. J Nucl Med. 1998; 39: 1662–1666.
Dakik HA, Vempathy H, Verani MS. Tolerance, hemodynamic changes and safety of dobutamine stress perfusion imaging. J Nucl Cardiol. 1996; 3: 410–414.
Pennel DJ, Underwood RS, Ell PJ. Safety of dobutamine stress for thallium-201 myocardial perfusion tomography in patients with asthma. Am J Cardiol. 1993; 71: 1346–1350.
Picano E, Mathias W, Bigi R, Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicenter study. Lancet 1994; 344: 1190–1192.
Elhendy A, Bax JJ, Poldermans D. Dobutamine stress myocardial perfusion imaging in coronary artery disease. J Nucl Med. 2002;43:1634–1646.
Elhendy A, van Domburg RT, Bax JJ, et al. Safety, hemodynamic profile, and feasibility of dobutamine stress technetium myocardial perfusion single-photon emission CT imaging for evaluation of coronary artery disease in the elderly. Chest 2000; 117: 649–656.
Elhendy A, van Domburg RT, Vantrimpont P, et al. Impact of heart transplantation on the safety and feasibility of the dobutamine stress test. J Heart Transplant 2001; 20: 399–406.
Gallik DM, Mahmarian JJ, Verani MS. Therapeutic significance of exercise-induced ST-segment elevation in patients without previous myocardial infarction. Am J Cardiol. 1993; 72: 1–7.
Elhendy A, Geleijnse ML, Roelandt JR, et al. Evaluation by quantitative 99m-technetium MIBI SPECT and echocardiography of myocardial perfusion and wall motion abnormalities in patients with dobutamine-induced ST-segment elevation. Am J Cardiol. 1995; 76: 441–448.
Maiaresse GH, Marwick TH, Vanoverschelde TL, et al. How accurate is dobutamine stress eletrocardiography for detection of coronary artery disease? J Am Coll Cardiol. 1994;24:920–927.
Yun JJ, Wu JC, Heller EN, et al. Dobutamine stress has limited value for enhancing flow heterogeneity in the presence of a moderate stenosis when used in conjunction with Tc-99m sestamibi imaging (abstract). J Am Coll Cardiol. 1995;25(supp A):217A.
Mirta R, Kazuya T, Frank D, et al. Arbutamine stress perfusion imaging in dogs with critical coronary artery stenosis: 99mTc-sestamibi versus 201-Tl. J Nucl Med. 2002; 43: 664–670.
Geleijnse ML, Elhendy A, Domburg RT, et al. Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain. J Am Coll Cardiol. 1996; 28: 447–454.
Schinkel AF, Elhendy A, van Domburg RT, et al. Prognostic value of dobutamine-atropine stress 99mTc-tetrafosmin myocardial perfusion SPECT in patients with known or suspected coronary artery disease. J Nucl Med. 2002; 43: 767–772.
Narula J, Dawson MS, Singh BK, et al. Noninvasive characterization of stunned, hibernating, remodelled and nonviable myocardium in ischemic cardiomyopathy. J Am Coll Cardiol. 2002; 36: 1913–1919.
Everaert H, Vanhove C, Franken PR. Effects of low-dose dobutamine on left ventricular function in normal subjects as assessed by gated single-photon emission tomography myocardial perfusion studies. Eur J Nucl Med. 1999; 26: 1298–1303.
Leoncini M, Sciagra R, Bellandi F, et al. Low-dose dobutamine nitrate-enhanced technetium 99m sestamibi gated SPECT versus low-dose dobutamine echocardiography for detecting reversible dysfunction in ischemic cardiomyopathy. J Nucl Cardiol. 2002; 9: 402–406.
Marwick TH. Arbutamine stress testing with closed loop drug delivery: toward the ideal or just another pharmacologic stress technique? J Am Coll Cardiol. 1995; 26: 1176–1179.
Cohen JL, Chan KL, Jaarsma W, et al. Arbutamine echocardiography: efficacy and safety of a new pharmacologic stress agent to induce myocardial ischemia and detect coronary artery disease. The International Arbutamine Study Group. J Am Coll Cardiol. 1995; 26: 1168–1175.
Anagnostopoulos C, Pennell D, Francis J, et al. A comparison of adenosine and arbutamine for myocardial perfusion imaging. Eur J Nucl Med. 1998; 25: 394–400.
Zoll PM. Resuscitation of the heart in ventricular standstill by external electrical stimulation. JAMA 1952; 247: 768–771.
Lee CY, Pellikka PA, McCully RB, et al. Nonexercise stress transthoracic echocardiography: transesophageal atrial pacing versus dobutamine stress. J Am Coll Cardiol. 1999;33:506–511.
Atar S, Cercek B, Nagai T, et al. Transthoracic stress echocardiography with transesophageal atrial pacing for bedside evaluation of inducible myocardial ischemia in patients with new-onset chest pain. Am J Cardiol. 2000; 86: 12–16.
Rainbird AJ, Pellikka PA, Stussy VL. et al. A rapid stress-testing protocol for the detection of coronary artery disease. J Am Coll Cardiol. 2000; 36: 1659–1663.
Lambertz H, Kreis A, Trumper H, et al. Simultaneous transesophageal atrial pacing and transesophageal two-dimensional echocardiography: a new method of stress echocardiography. J Am Coll Cardiol. 1990; 16: 1143–1153.
Gimenez VML. Ecocardiografia de Estresse. In Souza AGMR, Mansur A SOCESP Cardiologia,—1a ed. Vol. 2, Cap 20. São Paulo, Brazil: Atheneu;1996:173
Herd JA. Cardiovascular response to stress. Physiological Reviews 1991; 71: 305–330.
Manuck SB, Kaplan JR, Adams MR, Clarkson TB. Effects of stress and the sympathetic nervous system on coronary atherosclerosis in the cynomolgus macaque. Am Heart J. 1988; 116: 328–333.
Hjemdahl P, Fagius J, Freyschuss U, Wallin BG, Daleskog M, Bohlin G, Perski A. Muscle sympathetic activity and norephinephrine release during mental challenge in humans. Am J Physiol 1989; 257: E654–664.
Anderson EA, Sinkey CA, Mark A. Mental stress increases sympathetic nerve activity during sustained baroreceptor stimulation in humans. Hypertension. 1991;17(suppl III): III43–III49.
Linden W. What do arithmetic stress tests measure? Protocol variations and cardiovascular response. Psychophysiology 1991; 28 (1): 91–102.
Cincipirini PM. Cognitive stress and cardiovascular reactivity. I—Relationship to hypertension. Am Heart J. 1986; 112: 1044–1050.
Cinciprini PM. Cognitive stress and cardiovascular reactivity II—Relationship to atherosclerosis, arrhythmias and cognitive control. Am Heart J. 1986; 112: 1051–1065.
Specchia G, Servi E, Falcone C, Gavazzi A, Angoli L, Bramici E, Ardissimo D, Mussini A. Mental arithmetic stress testing in patients with coronary artery disease. Am Heart J. 1984; 108: 56–63.
Grossman P, Watkins LL, Wilhelm FH, Manolakis D, Lown B. Cardiac vagal control and dynamic responses to psychological stress among patients with coronary artery disease. Am J Cardiol. 1996; 78: 1424–1427.
Hines EABG. The cold pressure test for measuring the reactibility of the blood pressure: data concerning 571 normal and hypertensive subjects. Am Heart J. 1936; 11: 1–9.
McIlhany ML, Shaffer JW, Hines EA. The heritability of blood pressure: an investigation of 200 pairs of twins using the cold pressor test. Johns Hopkins Med J. 1975; 136: 57–64.
Stratton JR, Halter JB, Hallstrom AP, Caldwell JH, Ritchie JL. Comparative plasma catecholamine and hemodynamic responses to handgrip, cold pressor and supine bicycle exercise testing in normal subjects. J Am Coll Cardiol. 1983; 2: 93–104.
Backman C, Holm S, Linderholm H. Reaction to cold of patients with coronary insufficiency. Ups J Med Sci 1979; 84: 181–187.
Lassvik C, Areskog NH. Effects of various environmental temperatures on effort angina. Ups J Med Sci 1979; 84: 173–180.
Neill WA, Duncan DA, Kloster F, Mahler DJ. Response of coronary circulation to cutaneous cold. Am J Med. 1974; 56: 471–476.
Epstein SE, Stampfer M, Beiser GD, Goldstein RE, Braunwald E. Effects of a reduction in environmental temperature on the circulatory response to exercise in man. Implications concerning angina pectoris. N Engl J Med. 1969; 280: 7–11.
Mudge GH, Grossman W, Mills RM, Lesch M, Braunwald E. Reflex increase in coronary vascular resistance in patients with ischemic heart disease. N Engl J Med. 1976; 295: 1333–1337.
Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation. 1988;77:43–52.
Meeder JG, Peels HO, Blanksma PK, et al. Comparison between positron emission tomography myocardial perfusion imaging and intra-coronary doppler flow velocity measurements at rest and during cold pressor testing in angiographically normal coronary arteries in patients with one-vessel coronary artery disease. Am J Cardiol. 1996; 78: 526–531.
Meeder JG, Blanksma PK, van der Wall EE, et al. Coronary vasomotion in patients with syndrome X: evaluation with positron emission tomography and parametric myocardial perfusion imaging. Eur J Nucl Med. 1997; 24: 530–537.
Vita JA, Treasure CB, Yeung AC, et al. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation 1992; 85: 1390–1397.
Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83: 391–401.
Gould L. Cold pressor test in aortic stenosis and idiopathic hypertrophic subaortic stenosis. Preliminary report. Am J Cardiol. 1969; 23: 38–42.
Wasserman AG, Reiss L, Katz RJ, et al. Insensitivity of the cold pressor stimulation test for the diagnosis of coronary artery disease. Circulation 1983; 67: 1189–1193.
Seneviratne BI, Linton I, Wilkinson R, Rowe W, Spice M. Cold pressor test in diagnosis of coronary artery disease: echophonocardiographic method. BMJ. 1983; 286: 1924–1926.
Ferrara LA, Mancini M, De Simone GD, et al. Responses of serum insulin and blood pressure to cold and handgrip in obese patients. Int J Cardiol. 1991; 32: 353–359.
Verani MS, Zacca NM, DeBauche TL, Miller RR, Chahine RA. Comparison of cold pressor and exercise radionuclide angiocardiography in coronary artery disease. J Nucl Med. 1982; 23: 770–776.
Rootwelt K, Erikssen J, Nitter-Hauge S, Thaulow E. Detection of coronary artery disease with gated cardiac blood-pool scintigraphy: comparison of cold pressor test and dynamic exercise. Clin Physiol 1982; 2: 459–465.
Vojacek J, Hannan WJ, Muir AL. Ventricular response to dynamic exercise and the cold pressor test. Eur Heart J. 1982; 3: 212–222.
Ahmad M, Dubiel JP, Haibach H. Cold pressor thallium-201 myocardial scintigraphy in the diagnosis of coronary artery disease. Am J Cardiol. 1982; 50: 1253–1257.
Hendel RC, Jamil T, Glover DK. Pharmacologic stress testing: new methods and new agents. J Nucl Cardiol. 2003; 10: 197–204.
Coronary artery surgery study (CASS): A randomized trial of coronary bypass surgery. Survival data. Circulation 1983; 68: 939–950.
Schneider JF, Thomas HE Jr, Sorlie P, et al. Comparative features of newly acquired left and right bundle branch block in the general population: The Framingham study. Am J Cardiol. 1981; 47: 931–940.
Fahy GJ, Pinski SL, Miller DP, et al. Natural history of isolated bundle branch block. Am J Cardiol. 1996; 77: 1185–1190.
Hirzel HO, Senn M, Nuesch K, et al. Thallium-201 scintigraphy in complete left bundle branch block. Am J Cardiol. 1984; 53: 764–769.
Burns RJ, Galligan L, Wright L, et al. Improved specificity of myocardial thallium 201 single photon emission computed tomography in patients with left bundle branch block by dipyridamole. Am J Cardiol. 1991;68:504–508
Hammermeister KE, DeRouen TA, Dodge HT, et al. Prognostic and predictive value of exertional hypotension in suspected coronary heart disease. Am J Cardiol. 1983; 51: 1261–1266.
Sandvik L, Erikssen J, Ellestad M, et al. Heart rate increase and maximal heart rate during exercise as predictors of cardiovascular mortality: a 16 year follow-up of 1960 healthy men. Coron Artery Dis 1995; 6: 667–679.
Simons M, Parker JA, Udelson JE, Gervino EV. The role of clinical data in interpretation of perfusion images. J Nucl Med. 1994; 35: 740–741.
Mitchell JH, Blomqvist G. Maximal oxygen uptake. N Engl J Med. 1971 6;284(18):1018–1022.
Boz A, Gungor F, Karayalcin B, Yildiz A. The effects of solid food in prevention of intestinal activity in 99mTc tetrofosmin myocardial perfusion scintigraphy. J Nucl Cardiol. 2003; 10: 161–167.
Feldman RL, Nichols WM, Pepine CJ, Conti CR. Acute effects of intravenous dipyridamole on regional coronary hemodynamics and metabolism. Circulation 1981; 64: 333–334.
Gould KL, Hamilton GW, Lipscomb K, Ritchie JL, Kennedy W. Method for assessing stress induced regional malperfusion during coronary arteriography. Am J Cardiol. 1974; 34: 557–564.
Klodas E, Miller TD, Christian TF, et al. Prognostic significance of ischemic electrocardiographic changes during vasodilator stress testing in patients with normal SPECT images. J Nucl Cardiol. 2003; 10: 4–8.
Abbott BG, Afshar M, Berger AK, Wackers FJ. Prognostic significance of ischemic electrocardiographic changes during adenosine infusion in patients with normal myocardial perfusion imaging. J Nucl Cardiol. 2003; 10: 9–16.
Riou LM, Ruiz M, Rieger JM, et al. Influence of propanolol, enalaprilat, verapamil, and caffeine on adenosine A(2A)-receptor-mediated coronary vasodilation. J Am Coll Cardiol. 2002; 40: 1687–1694.
Sharir T, Rabinowitz B, Livschitz S, et al. Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. J Am Coll Cardiol. 1998; 31: 1540–1546.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag New York, LLC
About this chapter
Cite this chapter
Vitola, J.V., Kormann, O.J., Stier, A.L., Chalela, W.A., Mastrocolla, L.E., Delbeke, D. (2004). Stress Modalities to Evaluate Myocardial Perfusion. In: Vitola, J.V., Delbeke, D. (eds) Nuclear Cardiology and Correlative Imaging. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2038-1_4
Download citation
DOI: https://doi.org/10.1007/978-1-4612-2038-1_4
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-20707-0
Online ISBN: 978-1-4612-2038-1
eBook Packages: Springer Book Archive